Advertisement
Screener

BRAIN SCIENTIFIC INC. Net Change in Cash

BRAIN SCIENTIFIC INC. Net Change in Cash

BRAIN SCIENTIFIC INC. reported Net Change in Cash of -$37.65 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-31.

Discontinued › Cash Flow › Change in Cash

us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect · last filed 2023-03-31

  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2022-03-31 was -$439.00K, a 170.03% decline year-over-year.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2021-03-31 was $626.90K.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2020-03-31 was -$233.49K.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for the quarter ending 2019-03-31 was -$119.81K.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2022 was -$37.65K, a 105.26% decline from fiscal 2021.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2021 was $716.42K.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2020 was -$100.56K, a 202.74% decline from fiscal 2019.
  • BRAIN SCIENTIFIC INC. cash, cash equivalents, restricted cash and restricted cash equivalents, period increase (decrease), including exchange rate effect for fiscal 2019 was $97.87K.
Period endCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 3 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 6 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 9 month as first filedCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 monthCash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 12 month as first filed
2022-12-31-$37.65K
10-K · filed 2023-03-31
2022-09-30$1.24M
10-Q · filed 2022-11-14
2022-06-30$2.76M
10-Q · filed 2022-08-15
2022-03-31-$439.00K
10-Q · filed 2022-05-13
2021-12-31$716.42K
10-K · filed 2023-03-31
2021-09-30$37.02K
10-Q · filed 2022-11-14
-$246.34K
10-Q · filed 2021-11-15
2021-06-30$1.13M
10-Q · filed 2022-08-15
-$187.64K
10-Q · filed 2021-08-23
2021-03-31$626.90K
10-Q · filed 2022-05-13
-$177.67K
10-Q · filed 2021-05-24
2020-12-31-$100.56K
10-K · filed 2022-03-31
$11.42K
10-K · filed 2021-04-15
2020-09-30-$185.68K
10-Q · filed 2021-11-15
2020-06-30-$193.44K
10-Q · filed 2021-08-23
2020-03-31-$233.49K
10-Q · filed 2021-05-24
2019-12-31$97.87K
10-K · filed 2021-04-15
2019-09-30-$141.09K
10-Q · filed 2020-11-19
2019-06-30-$136.58K
10-Q · filed 2020-08-19
2019-03-31-$119.81K
10-Q/A · filed 2020-09-16